U.S. Stem Cell, Inc.
USRM
$0.0001
$0.000.00%
| 12/31/2022 | 09/30/2022 | 06/30/2022 | 03/31/2022 | 12/31/2021 | |
|---|---|---|---|---|---|
| Revenue | 82.00K | 85.60K | 128.70K | 139.60K | 200.70K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 82.00K | 85.60K | 128.70K | 139.60K | 200.70K |
| Cost of Revenue | 23.70K | 27.40K | 36.30K | 43.80K | 52.00K |
| Gross Profit | 58.40K | 58.30K | 92.40K | 95.90K | 148.80K |
| SG&A Expenses | 1.78M | 1.77M | 1.91M | 2.26M | 2.28M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 1.80M | 1.79M | 1.95M | 2.30M | 2.34M |
| Operating Income | -1.72M | -1.71M | -1.82M | -2.16M | -2.14M |
| Income Before Tax | -2.86M | -2.93M | -3.04M | -3.46M | -3.29M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -2.86 | -2.93 | -3.04 | -3.46 | -3.29 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -2.86M | -2.93M | -3.04M | -3.46M | -3.29M |
| EBIT | -1.72M | -1.71M | -1.82M | -2.16M | -2.14M |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 |
| Normalized Basic EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS Diluted | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 |
| Normalized Diluted EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Average Basic Shares Outstanding | 2.37B | 2.22B | 2.07B | 1.92B | 1.84B |
| Average Diluted Shares Outstanding | 2.37B | 2.22B | 2.07B | 1.92B | 1.84B |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
